Intervention

buprenorphine-naloxone (Suboxone) for 12 weeks

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

1 shown

HIV Risk Reduction in Subutex Injectors in TbilisiNCT01131273 · 2010-06-01

COMPLETED

Common conditions

HIV1

Leading sponsors

University of Pennsylvania1

Trial status mix

COMPLETED1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.